IDEXX launches USDA-approved Swine Influenza Virus Ab Test, helping laboratories screen more confidently and conveniently

WESTBROOK, Maine, June 13, 2014—IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced U.S. Department of Agriculture (USDA) approval of the company’s Swine Influenza Virus Ab Test. The new enzyme-linked immunosorbent assay (ELISA) detects antibodies to all influenza type A viruses, giving laboratories a single tool to confidently screen for and monitor swine influenza.

In addition to its broad detection capabilities, the IDEXX Swine Influenza Virus Ab Test demonstrates high sensitivity, accurately detecting antibodies to nucleoprotein (NP) of swine influenza virus within 14 days of initial infection. “Influenza virus is always changing, which is why we developed one test that screens for multiple swine subtypes,” said Olivier te Boekhorst, Vice President and General Manager, IDEXX Livestock, Poultry and Dairy. “Knowing that the test is manufactured under the stringent quality control systems of IDEXX and is USDA approved, laboratories and their swine industry customers can be confident in the results of this broad screen.”

Swine influenza is a significant respiratory disease that causes high morbidity and can lead to reproductive failure in sows. The virus presents with coughing, dyspnea and fever, and can be endemic in contemporary swine herds. In addition, when influenza occurs concurrently with other swine respiratory pathogens, the clinical and economic impact is worse. Timely detection is important for producers who need to document the health of animals before export or sale, and/or monitor herds for exposure to the disease. Because the IDEXX Swine Influenza Virus Ab Test uses a strip-plate rather than a solid-plate format, laboratories can run as few or as many tests as needed. This not only provides flexibility and convenience, but increases laboratory efficiency and decreases waste.

The IDEXX Swine Influenza Virus Ab Test is now available in the United States, Canada and Mexico. For more information on the IDEXX Swine Influenza Virus Ab Test, contact Paulette Barter, U.S. Sales Manager, IDEXX Livestock, Poultry and Dairy, at 1-207-556-8680.

About IDEXX Livestock, Poultry and Dairy
Livestock and poultry producers, laboratories, veterinarians and dairy processors depend on IDEXX diagnostic technologies to make confident decisions about animal health, disease management and reproductive efficiency, and to ensure consumers have access to safe, healthy food and milk. Reproducibility, reliability and accuracy are three of the reasons why more than 1 billion IDEXX tests—including dairy residue tests and milk-based diagnostics—have been run worldwide since 1985.

About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 5,500 people and offers products to customers in over 175 countries.

Note Regarding Forward-Looking Statements
This news release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as “expects,” “may,” “anticipates,” “intends,” “would,” “will,” “plans,” “believes,” “estimates,” “should,” and similar words and expressions. These forward-looking statements are based on management’s current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review the Company’s filings with the United States Securities and Exchange Commission (which are available from the SEC’s EDGAR database at www.sec.gov, at various SEC reference facilities in the United States and via the Company’s website).

Contact

IDEXX Laboratories, Inc.
Christa Goodell
Swine Marketing Manager
+1-207-556-6395